Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Elicio Therapeutics, Inc. | 7,900 | reported | 19 May 2025 | tx 3+16,100 |
| Aptose Biosciences Inc. | 3,333 | reported | 05 Feb 2024 | tx 7+358,333 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2025 | GRANT_AWARD | Elicio Therapeutics, Inc. | 7,900 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | Elicio Therapeutics, Inc. | 4,100 | 0.00 USD | deriv |
| 05 Feb 2024 | GRANT_AWARD | Aptose Biosciences Inc. | 3,333 | 0.00 USD | deriv |
| 28 Dec 2023 | GRANT_AWARD | Elicio Therapeutics, Inc. | 4,100 | 0.00 USD | deriv |
| 19 Jan 2023 | GRANT_AWARD | Aptose Biosciences Inc. | 100,000 | 0.00 USD | deriv |
| 18 Jan 2022 | GRANT_AWARD | Aptose Biosciences Inc. | 50,000 | 0.00 USD | deriv |
| 04 Jan 2021 | GRANT_AWARD | Aptose Biosciences Inc. | 50,000 | 0.00 USD | deriv |
| 11 Mar 2020 | GRANT_AWARD | Aptose Biosciences Inc. | 50,000 | 0.00 USD | deriv |
| 31 Jan 2020 | GRANT_AWARD | Aptose Biosciences Inc. | 65,000 | 0.00 USD | deriv |
| 02 Jan 2019 | GRANT_AWARD | Aptose Biosciences Inc. | 40,000 | 0.00 USD | deriv |